SAR of tertiary carbinamine derived BACE1 inhibitors: role of aspartate ligand amine pKa in enzyme inhibition.

The optimization of tertiary carbinamine derived inhibitors of BACE1 from its discovery as an unstable lead to low nanomolar cell active compounds is described. Five-membered heterocycles are reported as stable and potency enhancing linkers. In the course of this work, we have discovered a clear trend where the activity of inhibitors at a given assay pH is dependent on pK(a) of the amino group that interacts directly with the catalytic aspartates. The potency of compounds as inhibitors of Alphabeta production in a cell culture assay correlated much better with BACE1 enzyme potency measured at pH 7.5 than at pH 4.5.

[1]  Min Xu,et al.  Discovery of oxadiazoyl tertiary carbinamine inhibitors of beta-secretase (BACE-1). , 2006, Journal of medicinal chemistry.

[2]  Alison R. Gregro,et al.  Evolution of Tertiary Carbinamine BACE‐1 Inhibitors: Aβ Reduction in Rhesus CSF upon Oral Dosing , 2009, ChemMedChem.

[3]  C. Supuran,et al.  Inhibitors of HIV-1 protease: 10 years after , 2006 .

[4]  D. Hazuda,et al.  Design, synthesis, and SAR of macrocyclic tertiary carbinamine BACE-1 inhibitors. , 2007, Bioorganic & medicinal chemistry letters.

[5]  Alison R. Gregro,et al.  Discovery and SAR of isonicotinamide BACE-1 inhibitors that bind beta-secretase in a N-terminal 10s-loop down conformation. , 2007, Bioorganic & medicinal chemistry letters.

[6]  I. Kola,et al.  BACE knockout mice are healthy despite lacking the primary beta-secretase activity in brain: implications for Alzheimer's disease therapeutics. , 2001, Human molecular genetics.

[7]  Y. Kiso,et al.  Recent progress in the drug discovery of non-peptidic BACE1 inhibitors , 2009, Expert opinion on drug discovery.

[8]  S. Hitchcock,et al.  Structure-brain exposure relationships. , 2006, Journal of medicinal chemistry.

[9]  R. Nussbaum,et al.  Alzheimer's disease and Parkinson's disease. , 2003, The New England journal of medicine.

[10]  Amy S. Espeseth,et al.  Discovery of aminoheterocycles as a novel beta-secretase inhibitor class: pH dependence on binding activity part 1. , 2009, Bioorganic & medicinal chemistry letters.

[11]  Wickliffe C Abraham,et al.  Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory , 2003, Progress in Neurobiology.